CCM
SGTX

CAAS Capital Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

CAAS Capital Management’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,692
Closed -$782K – 1063
2021
Q1 		$782K Hold
2,692
– – 0.01% 471
2020
Q4 		$1.68M Buy
+2,692
New +$1.68M 0.02% 236